Lakkaraju Roop Kalyan
Known title: EVP, Chief Financial OfficerCIK: 0001396867
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Benchmark Electronics Shares Decline Ahead of Q3 Earnings. Benchmark Electronics shares are falling alongside other tech-related names as the company prepares to announce its third-quarter 2026 results. The stock is currently trading near a key support level, reflecting recent selling pressure. Investors are watching this earnings report closely to gauge the company's performance against its high valuation metrics.
Transaction History
| BIO | ▲ Buy | Option Exercise | 1,536 | $0 | 9/6/2026 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 782 | $302K | 9/6/2026 | View on chart |
| BIO | ▲ Buy | Option Exercise | 1,370 | $0 | 9/5/2026 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 559 | $216K | 9/5/2026 | View on chart |
| BIO | ▲ Buy | Option Exercise | 1,078 | $0 | 4/24/2026 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 420 | $121K | 4/24/2026 | View on chart |
| BIO | ▲ Buy | Option Exercise | 1,535 | $0 | 9/6/2025 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 550 | $162K | 9/6/2025 | View on chart |
| BIO | ▲ Buy | Option Exercise | 1,077 | $0 | 4/24/2025 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 386 | $96K | 4/24/2025 | View on chart |
| BHE | ▼ Sell | Tax Withholding | 2,801 | $84K | 2/26/2024 | View on chart |
| BHE | ▼ Sell | Tax Withholding | 3,219 | $96K | 2/23/2024 | View on chart |
| BHE | ▲ Buy | Grant | 25,321 | $0 | 2/22/2024 | View on chart |
| BHE | ▲ Buy | Option Exercise | 19,516 | $0 | 2/20/2024 | View on chart |
| BHE | ▼ Sell | Tax Withholding | 13,318 | $389K | 2/20/2024 | View on chart |
| BHE | ▼ Sell | Tax Withholding | 2,801 | $66K | 2/27/2023 | View on chart |
| BHE | ▲ Buy | Grant | 27,653 | $0 | 2/23/2023 | View on chart |
| BHE | ▲ Buy | Option Exercise | 13,983 | $0 | 2/22/2023 | View on chart |
| BHE | ▲ Buy | Option Exercise | 14,573 | $0 | 2/22/2023 | View on chart |
| BHE | ▼ Sell | Tax Withholding | 13,351 | $324K | 2/22/2023 | View on chart |
| BHE | ▼ Sell | Tax Withholding | 7,956 | $193K | 2/21/2023 | View on chart |
| BHE | ▲ Buy | Grant | 24,067 | $0 | 2/25/2022 | View on chart |
| BHE | ▼ Sell | Tax Withholding | 5,767 | $147K | 2/22/2022 | View on chart |
| BHE | ▼ Sell | Tax Withholding | 1,593 | $42K | 1/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth
The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth. The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.